Validation of an obstetric comorbidity index in an external population

被引:123
|
作者
Metcalfe, A. [1 ]
Lix, L. M. [2 ]
Johnson, J-A [1 ]
Currie, G. [3 ,4 ]
Lyon, A. W. [5 ]
Bernier, F. [6 ]
Tough, S. C. [3 ,4 ]
机构
[1] Univ Calgary, Dept Obstet & Gynaecol, Calgary, AB, Canada
[2] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada
[3] Univ Calgary, Dept Paediat, Calgary, AB T2N 1N4, Canada
[4] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
[5] Univ Saskatchewan, Dept Pathol & Lab Med, Saskatoon Hlth Reg & Coll Med, Saskatoon, SK, Canada
[6] Univ Calgary, Dept Clin Genet, Calgary, AB, Canada
基金
加拿大健康研究院;
关键词
Comorbidity; International Classification of Diseases; pregnancy; prevalence; validation; HOSPITAL DISCHARGE DATA; PREGNANCY-ASSOCIATED HOSPITALIZATIONS; MATERNAL MEDICAL CONDITIONS; UNITED-STATES; MORBIDITY; COMPLICATIONS; PERFORMANCE; INFORMATION; PREVALENCE; IMPACT;
D O I
10.1111/1471-0528.13254
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
ObjectivesAn obstetric comorbidity index has been developed recently with superior performance characteristics relative to general comorbidity measures in an obstetric population. This study aimed to externally validate this index and to examine the impact of including hospitalisation/delivery records only when estimating comorbidity prevalence and discriminative performance of the obstetric comorbidity index. DesignValidation study. SettingAlberta, Canada. PopulationPregnant women who delivered a live or stillborn infant in hospital (n=5995). MethodsAdministrative databases were linked to create a population-based cohort. Comorbid conditions were identified from diagnoses for the delivery hospitalisation, all hospitalisations and all healthcare contacts (i.e. hospitalisations, emergency room visits and physician visits) that occurred during pregnancy and 3months pre-conception. Logistic regression was used to test the discriminative performance of the comorbidity index. Main outcome measuresMaternal end-organ damage and extended length of stay for delivery. ResultsAlthough prevalence estimates for comorbid conditions were consistently lower in delivery records and hospitalisation data than in data for all healthcare contacts, the discriminative performance of the comorbidity index was constant for maternal end-organ damage [all healthcare contacts area under the receiver operating characteristic curve (AUC)=0.70; hospitalisation data AUC=0.67; delivery data AUC=0.65] and extended length of stay for delivery (all healthcare contacts AUC=0.60; hospitalisation data AUC=0.58; delivery data AUC=0.58). ConclusionsThe obstetric comorbidity index shows similar performance characteristics in an external population and is a valid measure of comorbidity in an obstetric population. Furthermore, the discriminative performance of the comorbidity index was similar for comorbidities ascertained at the time of delivery, in hospitalisation data or through all healthcare contacts.
引用
收藏
页码:1748 / 1755
页数:8
相关论文
共 50 条
  • [31] Development and validation of a Medicines Comorbidity Index for older people
    Narayan, Sujita W.
    Nishtala, Prasad S.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (12) : 1665 - 1672
  • [32] Recurrent Severe Maternal Morbidity in an Obstetric Population With a High Comorbidity Burden
    McIlwraith, Claire
    Sanusi, Ayodeji
    McGwin Jr, Gerald
    Battarbee, Ashley
    Subramaniam, Akila
    OBSTETRICS AND GYNECOLOGY, 2024, 143 (02): : 265 - 271
  • [33] Validation of a modified obstetric comorbidity index for prediction of postpartum adverse events including fetal morbidity - a retrospective cohort study from Qatar
    Chaalan, Fouad
    Minisha, Fathima
    Zaidi, Zehra
    Babekar, Alaa
    Saleh, Huda Abullah Hussain
    Shurbak, Zeena Saeed Bu
    Al Baloushi, Mariam
    Alnaama, Alaa
    Ahmed, Husham
    Babarinsa, Isaac
    Dewik, Nader Al
    Pallivalapila, Abdulrouf
    Olagundoye, Victor
    Farrell, Thomas
    BMC PREGNANCY AND CHILDBIRTH, 2024, 24 (01)
  • [34] Validation of the Charlson Comorbidity Index for predicting functional outcome of stroke
    Tessier, Annie
    Finch, Lois
    Daskalopoulou, Stella S.
    Mayo, Nancy E.
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2008, 89 (07): : 1276 - 1283
  • [35] DEVELOPMENT AND VALIDATION OF THE MORTALITY RISK FOR TRAUMA (MORT) COMORBIDITY INDEX
    Thompson, Hilaire
    Nathens, Avery
    Rivara, Frederick
    Wang, Jin
    Heagerty, Patrick
    Jurkovich, Gregory
    Mackenzie, Ellen
    JOURNAL OF NEUROTRAUMA, 2009, 26 (08) : A50 - A50
  • [36] Validation of a Modified Comorbidity Index for Allogeneic Hematopoietic Cell Transplant
    Defor, Todd E.
    Le, Chap
    Smith, Angela R.
    Warlick, Erica D.
    Bejanyan, Nelli
    Weisdorf, Daniel J.
    BLOOD, 2016, 128 (22)
  • [37] Development and validation of a dialysis-specific comorbidity index.
    Miskulin, DC
    Martin, AA
    Levey, AS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 613A - 613A
  • [38] The Chiari Severity Index and the role of external validation
    Greenberg, Jacob K.
    Limbrick Jr, David D.
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2021, 27 (02) : 241 - 242
  • [39] External validation of the paediatric risk of malignancy index
    Hermans, A. J.
    Kluivers, K. B.
    Massuger, L. F.
    Coppus, S. F.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2016, 123 (03) : 448 - 452
  • [40] External Validation of the Prostate Cancer Specific Comorbidity Index: A Claims Based Tool for the Prediction of Life Expectancy in Men with Prostate Cancer
    Gore, John L.
    JOURNAL OF UROLOGY, 2019, 202 (03): : 524 - 524